‌

US Patent 9549852 Scleral and conjuctival implants for drug therapy

Patent 9549852 was granted and assigned to Mati Therapeutics on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Mati Therapeutics

Current Assignee

Mati Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9549852

Date of Patent

January 24, 2017

Patent Application Number

14858555

Date Filed

September 18, 2015

Patent Primary Examiner

‌

Carlos Azpuru

Patent abstract

An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.